Clinical Trials Browser

Phase 1/2 × Osteosarcoma × Docetaxel × Clear all

NCT03598595 2026-02-04

Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma

Phase 1/2 Active not recruiting

Osteosarcoma